Ciitizen, based in Palo Alto, California, published a report card that uses a five-star system to rate how health care providers comply with federal rules governing record requests.
In less than two years after it closed its 14th fund raising $1.5 billion, Norwest Venture Partners announced last week that it has closed its next fund with a whopping $2 billion to invest in consumer, healthcare and tech startups.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The funding came from various investors, including First Trust Capital Partners, OCA Ventures and Spectrum Health Ventures, among others.
The company, which builds subsidiary companies centered around genetically driven diseases, said it would trade on the Nasdaq under the ticker symbol BBIO.
The startup leverages machine learning to help predict which people are likely to become high-cost members before a high-cost health event occurs.
The company, Meru Health, said it will use the financing to support additional clinical validation and to prepare to roll its offering out to health systems and large employers in several states.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Despite a couple of flaws, Alex Gibney's new film - airing March 18 - expertly portrays how Elizabeth Holmes's dream of changing the world of lab testing became a fraud.
The Palo Alto startup has developed an AI-based system that can screen the retinal images of newborn babies to highlight potential eye conditions that require follow-up and treatment.
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
The company sources product candidates from academic and commercial research and then launches subsidiary companies to develop them.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The report, by law firm WSGR, noted an almost twofold increase in life sciences IPOs - especially biotech - and a greater number priced at $250 million or more.
Merck and Palantir Technologies are forming a joint research venture called Syntropy as a way to offer data analytics tools to healthcare organizations.
The selection process whittled the prospective candidate pool down from 700 companies to five finalists tackling healthcare problems ranging from women's health to ophthalmology.
The money will fund its preclinical immuno-oncology programs. It also hired Achaogen exec Adrian Jubb as chief medical officer and Genentech's An Song as SVP of development sciences.
By teaming up, SAP employees will be able to use Cognoa's app to screen their children for developmental delays in language, behavior and other areas.